Home › Head and Neck Squamous Cell Carcinoma › Vermont
Head and Neck Squamous Cell Carcinoma clinical trials in Vermont
3 studies for Head and Neck Squamous Cell Carcinoma are looking for participants at sites in Vermont.
BiCaZO: A Study Combining Two Immunotherapies (Cabozantinib and Nivolumab) to Treat Patients With Advanced Melanoma or Squamous Cell Head and Neck Cancer, an immunoMATCH Pilot Study
- Dartmouth Cancer Center - North, Saint Johnsbury
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Sep 25, 2026 · NCT05136196Comparing Sentinel Lymph Node (SLN) Biopsy With Standard Neck Dissection for Patients With Early-Stage Oral Cavity Cancer
- Central Vermont Medical Center/National Life Cancer Treatment, Berlin Corners
- University of Vermont Medical Center, Burlington
- University of Vermont and State Agricultural College, Burlington
RecruitingPhase 2/3
Ages 18 and older · All sexes · Updated Aug 17, 2026 · NCT04333537Testing the Addition of the Drug BMX-001, a Radioprotector, or a Placebo to the Usual Chemoradiation Therapy for Patients With Head and Neck Cancer
- Dartmouth Cancer Center - North, Saint Johnsbury
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Aug 17, 2026 · NCT06532279From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.